Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Biohaven Pharmaceutical Holding Co Ltd. | a2234751z10-k.htm |
| EX-32.1 - EX-32.1 - Biohaven Pharmaceutical Holding Co Ltd. | a2234751zex-32_1.htm |
| EX-31.2 - EX-31.2 - Biohaven Pharmaceutical Holding Co Ltd. | a2234751zex-31_2.htm |
| EX-31.1 - EX-31.1 - Biohaven Pharmaceutical Holding Co Ltd. | a2234751zex-31_1.htm |
| EX-21.1 - EX-21.1 - Biohaven Pharmaceutical Holding Co Ltd. | a2234751zex-21_1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-218193) of Biohaven Pharmaceutical Holding Company Ltd. of our report dated March 6, 2018 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Hartford,
Connecticut
March 6, 2018